The optimal opening angle of the Björk-Shiley tilting disc valve prosthesis

Likelihood of underreporting of outlet strut fracture from examination of the Dutch Björk-Shiley CC cohort

The Dutch Björk-Shiley convexo-concave (BScc) cohort serves as a reference population on the risk of outlet strut fracture and is being used to formulate guidelines for prophylactic replacement. Fractures, however, may be undetected at death. The aim of this study was to quantify the degree of underestimation of strut fracture in the Dutch BScc cohort. Multivariate Cox regression analysis was used to assess the relative and absolute risk of death from different causes within 14 years. The unexplained "excess" mortality among 70 degrees BScc valve recipients was attributed to unreported fatal strut fractures and used to estimate its extent in this group, which then was extrapolated to the 60 degrees BScc valve recipients. For 70 degrees BScc valve recipients, the adjusted hazard ratio for death from all causes except strut fracture was 1.2 (95% confidence interval [CI] 1.0 to 1.5). The 14-year absolute risks for 70 degrees and 60 degrees BScc valve recipients were 44% and 37%, respectively. Among 70 degrees and 60 degrees BScc valve recipients, underreporting of fracture was estimated to be 25% (95% CI 0 to 49) and 26% (95% CI 0 to 52), respectively. Estimates based on sudden death and fatal congestive heart failure yielded essentially the same results. Thus, underreporting of fatal strut fracture in the Dutch BScc cohort is estimated to be approximately 25%. Hence, the risk and lethality of fracture of BScc valves are underestimated and indications for prophylactic replacement should be adjusted accordingly. For example, the advantage of valve replacement in a 40-year-old patient with a 29-mm 60 micro BScc mitral valve would almost double to 0.82 years.

Quantitative detection of outlet strut separations in Björk-Shiley convexo-concave mitral valves

BACKGROUND

As of January 31, 1995, 564 outlet strut fractures (OSFs) of Björk-Shiley convexo-concave (BSCC) heart valves had been reported to the Shiley Heart Valve Research Center, of which approximately two thirds resulted in the death of the patient. Previous studies indicate that one leg of the outlet strut separates (single-leg separation, SLS) from the valve before the second leg breaks, which results in complete OSF. To identify those valves at risk of complete OSF, an in vivo radiographic imaging technique is being developed to evaluate the strut leg integrity. The goal of the present study was to develop an objective postprocessing technique to evaluate outlet strut leg integrity quantitatively in these cineradiographic images.

METHODS AND RESULTS

Twenty-two sets (12 intact valves, 10 SLS valves) of cineangiographic images were obtained from individuals whose valve status was subsequently verified ex vivo. Several quantitative measures of SLS were evaluated to identify possible loss of metal or gaps in the SLS legs. Two of these measures, decrease in pixel intensity (DIPI) ratio and gap half-width, are diagnostic metrics of SLS: i.e., the maximum likelihood estimate of the area under the receiver operating characteristic curve was 0.892 (SD, 0.066) for a model based on DIPI ratio and 0.802 (SD, 0.093) for gap half-width.

CONCLUSIONS

We have developed a postprocessing technique that can be used to objectively evaluate outlet strut integrity in cineradiographic images of BSCC heart valves. At an estimated specificity of 1.0, the estimated sensitivity of the objective review was comparable to that of a subjective expert review panel.

Five-year results after valve replacement with the Björk-Shiley 70 degrees convexo-concave prosthesis

In the 18 months up to July 1983, 120 Björk-Shiley convexo-concave prostheses with 70 degrees opening angle were implanted in 47 women and 61 men aged 19-78 (mean 58.6) years. The prosthetic valves were aortic in 65 cases, mitral in 23 and both aortic and mitral in 20 cases. Emergency operation was required in ten cases, and concomitant surgery was performed in 43 (39.8%). The early mortality was 5.5%. A follow-up study, comprising 498 patient years, revealed 73.1% 5-year survival. There were three mechanical failures of prosthesis, in one of which re-replacement was successful. Elective prosthesis replacement was performed in four other cases judged to be at high risk of strut fracture.

Development of an artificial heart valve

When I reviewed the 21-year results with the Björk-Shiley tilting disc valves, I found out that to date, we still have to use these disc valves and all mechanical heart valves with anticoagulation therapy. The highest incidence of valve-related postoperative deaths after aortic valve replacements in Stockholm was anticoagulation-related bleeding, which continued at a rate of about 1% year after year. There is a need to improve the quality of life for heart valve patients, especially for children, for young females who want to have children, for the older generation who are on medical treatment, and for all patients in whom long-term anticoagulation of a perfect quality is impossible to guarantee. A series of tests on goats has been performed, using the Björk-Shiley Monostrut valve used in 2,024 patients at the Karolinska Hospital in Stockholm and in 75,000 patients worldwide for up to 8 years with a modification of a microporous surface. In the mitral position, this modified partially microporous-surfaced Björk-Shiley Monostrut valve has permitted goats to live for 5 years with four normal pregnancies without anticoagulation therapy.

Heart valve replacement with the Björk-Shiley Monostrut valve: early results of a multicenter clinical investigation

To evaluate the clinical performance of the Björk-Shiley Monostrut prosthesis, five centers combined their early experience. Between May, 1982, and June, 1985, 537 prostheses were implanted in 486 patients at these centers: 246 patients had aortic valve replacement (AVR), 163 underwent mitral valve replacement (MVR), and 47 had double-valve replacement (DVR). Thirty patients underwent other, more complex procedures. Concomitant cardiac procedures were performed in altogether 25%. Overall hospital (30 days) mortality was 5.1% (3.6% for AVR, 4.3% for MVR, 8.3% for DVR, and 16.6% for other procedures). The patients were followed up at 6- to 9-month intervals from 6 to 48 months (mean follow-up, 33 months). Follow-up was 99.6% complete. Late mortality was 7.2%. The three-year survival rate was 91.0% for AVR, 92.3% for MVR, and 76.2% for DVR. There was no structural failure of the prosthesis. No instances of valve thrombosis and fatal thromboembolism occurred in anticoagulated patients. The three-year incidence of freedom from thromboembolic events (including TIA) was 89.8% for AVR, 94.9% for MVR, and 90.2% for DVR. Preoperative and postoperative data for the assessment of mechanical hemolysis was available in 60% of the patients. The degree of mechanical hemolysis was low and did not change with time. Although the follow-up is still short, the Björk-Shiley Monostrut prosthesis appears to represent an improvement over previous Björk-Shiley models, particularly with regard to durability.

The Monostrut Björk-Shiley heart valve

To avoid the possibility of a fracture of the welded two-armed outflow strut of the Björk-Shiley heart valve, since 1982 it has been machined from one piece of Haynes 25 in the form of a monostrut valve without welds. Of the first 864 patients with a monostrut Björk-Shiley valve implanted, 268 have now been followed up to 3 years. The clinical findings, as well as absence of hemolysis, excellent hemodynamics even with a narrow aortic root as demonstrated by transseptal cardiac catheterization and excellent functional improvement are reported. No valve thrombosis in patients receiving anticoagulant therapy was observed with valves in either the aortic or the mitral position and there was no case of mechanical failure.

Hemodynamic evaluation of the integral monostrut Björk-Shiley prosthesis in the aortic position

Between May, 1983, and November, 1984, the new integral monostrut Björk-Shiley prosthesis was used for aortic valve replacement in 62 patients. The prosthesis is machined from a solid piece of cobalt alloy and has no welded joints. The traditional U-shaped outlet strut has been replaced by a projecting metal finger that holds the disc in place. The disc opens to 70 degrees and is convexoconcave. Successful transseptal heart catheterization was performed in 23 patients an average of 6 months following operation to evaluate the hemodynamic performance of the prosthesis. The mean peak-to-peak gradient was 7.73 +/- 7.49 mm Hg (+/- standard deviation). In five valves it was 0, and in only three was it higher than 15 mm Hg. Significant peak gradients were directly related to the valve index (valve area/body surface area). Mean systolic gradient at rest was 12.7 +/- 6.27 mm Hg and did not increase after exercise. Effective orifice areas were adequate, and the discharge coefficient ranged from 0.77 for the 21-mm prosthesis to 0.48 for the 29-mm prosthesis. Minimal regurgitation, which was washed out on the next systole, was observed with all sizes of the prosthesis. Disc opening was maximal (70 degrees) in all but one of the observed instances. Longer clinical follow-up is required, but the new integral monostrut Björk-Shiley prosthesis, with its important design changes and excellent hemodynamic performance, appears to be a promising aortic valve substitute.

The monostrut strength

The fatigue endurance limit for Haynes 25 from which the Björk-Shiley (B-S) valve is made is 4900 kg per square centimeter (70000 pounds per square inch). A welded strut may have a variation of fatigue endurance limit from 4900 kg per square centimeter (70000 pounds per square inch) in an incomplete weld with phase segregation. To avoid a weld with this variation, the monostrut has been developed, where the valve is made by electrochemical machining from one piece of Haynes 25. The homogenous outflow monostrut will then have a stable fatigue endurance limit of 4900 kg per square centimeter (70000 pounds per square inch). In a pulse duplicator at a pulse rate of 120 and a peak ventricular pressure of 200 mmHg, the maximum inservice tensile stresses for the 29 mm valve outflow strut do not exceed 700 kg per square centimeter (9800 pounds per square inch). Therefore, a seven times safety limit is present for the monostrut under maximal physiological stress conditions. The struts in the B-S monostrut valve cannot be fractured even under extreme experimental conditions and never under peak physiological conditions.

Optimal insertion technique for the Björk-Shiley valve in the narrow aortic ostium

The Björk-Shiley tilting disc valve was used for aortic valve replacement (AVR) in 250 consecutive patients between 1977 and 1982. One hundred and ninety-six patients had isolated AVR, and 54 had combined procedures (double- or triple-valve replacement in 31, associated coronary artery bypass grafting in 20, and miscellaneous procedures in 3). A special technique for inserting large Björk-Shiley valves without using outflow patches or annuloplastic procedures was developed. This method included allowing the right portion of the aortic incision to end about 0.5 cm above the noncoronary sinus; the use of simple interrupted sutures; placement of the prosthetic sewing ring on top of the annulus of the noncoronary sinus, thereby tilting the valve slightly in the outflow tract; and routine orientation of the major opening of the valve toward the annulus of the noncoronary sinus. This orientation resulted in the largest effective orifice area at postoperative catheterization. None of the male patients received a valve smaller than 23 mm, and none of the female patients were given a valve smaller than 21 mm. The convexoconcave model of the Björk-Shiley valve was used in 71% of the patients. An outflow patch was required only in 1 patient with concomitant supravalvular stenosis of the aorta. The combination of adequate myocardial protection, comparatively short aortic cross-clamping times, and the use of large, properly oriented Björk-Shiley valves resulted in satisfactory postoperative hemodynamics in all patients. In fact, none of the 196 patients undergoing isolated AVR and only 5 (9%) of the 54 patients undergoing combined procedures required postoperative inotropic stimulation. There were no operative deaths, and all patients left the hospital in good condition. The Björk-Shiley tilting disc valve is a reliable and well-functioning aortic valve substitute that is particularly suited for patients with narrow aortic ostia. With attention to certain details in the insertion technique, encouraging clinical results can be obtained with this prosthesis.